Trial intelligence / Profile preview

CoQ10 in Acute Myeloid Leukemia

IRCT20190924044867N2Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of coenzyme q10 in acute myeloid leukemia (AML), sponsored by Shiraz University of Medical Sciences. Started Jun 2020; status: completed.

02

Drugs

coenzyme q10
03

Conditions

acute myeloid leukemia (AML)

Beyond the preview

Go deeper on IRCT20190924044867N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190924044867N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call